Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Veronique M. Neumeister

Nuclear IRF-1 Expression as a Mechanism to Assess “Capability” to Express PD-L1 and Response to PD-1 Therapy in Metastatic Melanoma

Journal for ImmunoTherapy of Cancer

Molecular Medicine

Cancer Research

English

ErbB Activation Signatures as Potential Biomarkers for Anti-ErbB3 Treatment in HNSCC

Multidisciplinary

English

Related publications

Melanoma-Specific MHC-II Expression Represents a Tumour-Autonomous Phenotype and Predicts Response to Anti-Pd-1/Pd-L1 Therapy

Nature Communications

Molecular Biology

English

Testing PD-1/PD-L1 Expression in Cancer Therapy: Pathologic Insights and Economic Sustainability

Archives of Pathology and Laboratory Medicine

Forensic Medicine

Medical Laboratory Technology

English

Oncolytic Virus and PD-1/PD-L1 Blockade Combination Therapy

Oncolytic Virotherapy

English

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

English

Microsatellite Instability Status Predicts Response to Anti-Pd-1/Pd-L1 Therapy Regardless the Histotype: A Comment on Recent Advances

Bosnian Journal of Basic Medical Sciences

English

Complete Response to Anti-Pd-1 Antibody Monotherapy in Metastatic Melanoma-Can Therapy Be Discontinued? A Review of Current Literature

Journal of Cancer Biology and Therapeutics

English

ADAM10 and ADAM17 Cleave PD-L1 to Mediate PD-(L)1 Inhibitor Resistance

English

Reply to ‘Challenging PD-L1 Expressing Cytotoxic T Cells as a Predictor for Response to Immunotherapy in Melanoma’

Nature Communications

Molecular Biology

English

OR12: Expression and Localization of PD‐1 and PD‐L1 in Mouse Testes

American Journal of Reproductive Immunology

Reproductive Medicine

English